Диссертация (1174336), страница 31
Текст из файла (страница 31)
Rheumatol. – 2003. –Vol. 21, № 3. – P. 313-320.128. Flex, A. Pro-inflammatory genetic profiles in subjects with peripheralarterial occlusive disease and critical limb ischemia / A. Flex, E. Gaetani, F. Angelini// J. Intern. Med. – 2007. – Vol. 262, № 1.
– P. 124-130.129. Gallati, S. Disease-modifying genes and monogenic disorders: experiencein cystic fibrosis / S. Gallati // Appl. Clin. Genet. – 2014. – Vol. 10, № 7. – P. 133146.130. Gelse, K. Collagens – structure, function, and biosynthesis / K. Gelse, E.Poschl, T. Aigner // Adv. Drug Deliv. Rev. – 2003. – Vol. 55, № 12. – P. 1531-1546.131. Gene expression profiles reveal molecular mechanisms involved in theprogression and resolution of bleomycin-induced lung fibrosis / S.
Cabrera, M. Selman,A. Lozano-Bolaños, K. Konishi, T.J. Richards, N. Kaminski, A. Pardo // Am. J.Physiol. Lung Cell Mol. Physiol. – 2013. – Vol. 304, № 9. – P. L593-601.201132. Gene Modifier Study Group. Genetic modifiers of lung disease in cysticfibrosis / M.L. Drumm, M.W. Konstan, M.D. Schluchter, A. Handler, R. Pace, F. Zou,M.
Zariwala, D. Fargo, A. Xu, J.M. Dunn, R.J. Darrah, R. Dorfman, A.J. Sandford, M.Corey, J. Zielenski, P. Durie, K. Goddard, J.R. Yankaskas, F.A. Wright, M.R. Knowles// N. Engl. J. Med. – 2005. – Vol. 353, № 14. – P. 1443-1453.133. Genetic modifiers of severe liver disease in cystic fibrosis: a replicationstudy / J.R.
Stonebraker, K.J. Friedman, S.C. Ling, R.G. Pace, S.C. Bell, B. Bourke,G. Castaldo, C. Castellani, M. Cipolli, C. Colombo, J.L. Colombo, D. Debray, A.Fernandez // Pediatr. Pulmonol. Suppl. – 2007. – Vol. 30. – P. 381.134. Genetic polymorphisms in transforming growth factor beta-1 (TGFB1)and childhood asthma and atopy / H. Li, I.
Romieu, H. Wu, J.J. Sienra-Monge, M.Ramírez-Aguilar, B.E. del Río-Navarro, I.C. del Lara-Sánchez, E.O. Kistner, H.K.Gjessing, S.J. London // Hum. Genet. – 2007. – Vol. 121, № 5. – P.529-538.135. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) andtissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the developmentof ankylosing spondylitis / J.C. Wei, H.S. Lee, W.C.
Chen, L.J. Shiu, S.F. Yang, R.H.Wong // Ann. Rheum. Dis. – 2009. – Vol. 68, № 11. – P. 1781-1786.136. Genotype-phenotypeassociationofmatrixmetalloproteinase-3polymorphism and its synergistic effect with smoking on the occurrence of acutecoronary syndrome / P.Y. Liu, S.H. Chan, L.J. Lin, H.L. Wu, G.Y. Shi, J.H.
Chen //Am. J. Cardiol. – 2006. – Vol. 98, № 8. – P. 1012-1017.137. Genotypes and haplotypes of the VEGF gene are associated with highermortality and lower VEGF plasma levels in patients with ARDS / R. Zhai, M.N.Gong,W. Zhou, T.B. Thompson, P. Kraft, L. Su, D.C. Christiani // Thorax.
– 2007. – Vol.62, № 8. – P. 718-722.138. Genotypic variation in the transforming growth factor-beta1 gene:association with transforming growth factor-beta1 production, fibrotic lung disease,and graft fibrosis after lung transplantation / M.R. Awad, A. El-Gamel, P.
Hasleton,D.M. Turner, P.J. Sinnott, I.V. Hutchinson [et al.] // Transplantation. – 1998. – Vol.66, № 8. – P. 1014-1020.202139. Ghilardi, G. A single nucleotide in the matrix metalloproteinase 3promoter enhances breast cancer susceptibility / G. Ghilardi, M.L. Biondi, M. Caputo// Clin. Cancer Res. – 2002. – Vol. 8, № 12. – P. 3820-3823.140.
Glesby, M.J. Association of mitral valve prolapse and systemicabnormalities of connective tissue. A phenotypic continuum / M.J. Glesby, R.E. Pyeritz// JAMA. – 1989. – Vol. 262, № 4. – P. 523-528.141. Global analysis of gene expression in pulmonary fibrosis reveals distinctprograms regulating lung inflammation and fibrosis / N. Kaminski, J.D.
Allard, J.F.Pittet, F. Zuo, M.J. Griffiths, D. Morris, X. Huang, D. Sheppard, R.A. Heller // Proc.Natl. Acad. Sci. USA. – 2000. – Vol. 97, № 4. – P. 1778-1783.142. Global Strategy for Asthma Management and Prevention / GINA Report.– 2006. – 147 р.143. Glutathione S-transferase P1, maternal smoking, and asthma in children:a haplotype-based analysis / Y.F. Li, W.J. Gauderman, D.V. Conti, P.C. Lin, E. Avol,F.D.
Gilliland // Environ. Health Perspect. – 2008. –Vol. 116, № 3. – P. 409-415.144. Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms andseverity of lung disease in children with cystic fibrosis / C. Flamant, A. Henrion-Caude,P.Y. Boelle, F. Brémont, J. Brouard, B. Delaisi, J.F. Duhamel, C. Marguet, M.Roussey, M.C. Miesch, M. Boulé, R.C. Strange, A. Clement // Pharmacogenetics.
–2004. – Vol. 14, № 5. – P. 295-301.145. Guidelines for the management of primary biliary cirrhosis. TheIntractable Hepatobiliary Disease // Hepatology Research. – 2014. – Vol. 44 (suppl.1).– P. 71-90.146. Hall, N.F. Myopia and polymorphisms in genes for matrixmetalloproteinases / N.F.
Hall, C.R. Gale, S. Ye, C.N. Martyn // Invest. Ophthalmol.Vis. Sci. – 2009. – Vol. 50, № 6. – P. 2632-2636.147. Han, Y.P. Essential role of matrix metalloproteinases in interleukin-1induced myofibroblastic activation of hepatic stellate cell in collagen / Y.P. Han, L.Zhou, J. Wang // J. Biol. Chem. – 2004. – Vol. 279, № 6. – P. 4820-4828.203148.
Hurt, K. Cystic fibrosis: management of haemoptysis / K. Hurt, N.J.Simmonds // Paediatr Respir Rev. – 2012. – Vol. 13 (4). – Р. 200-5149. Hynes, R.O. The extracellular matrix: not just pretty fibrils / R.O. Hynes// Science. – 2009. – Vol. 326, № 5957. – P. 1216-1219.150. Identification of neutrophil activation markers as novel surrogate markersof CF lung disease / T. Rath, L.
Zwaschka, L. Hage, M. Kügler, K. Menendez, L.Naehrlich, R. Schulz, M. Roderfeld, E. Roeb // PLoS One. – 2014. – Vol. 9. – e115847.151. Identification of the cystic fibrosis gene: cloning and characterization ofcomplementary DNA / J.R. Riordan, J.M. Rommens, B. Kerem, N.
Alon, R. Rozmahel,Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J.L. Chou // Science. – 1989. – Vol.245, № 4922. – P. 1066-1073.152. Identification of the cystic fibrosis gene: genetic analysis / B. Kerem, J.M.Rommens, J.A. Buchanan, D. Markiewicz, T.K. Cox, A. Chakravarti, M. Buchwald,L.C. Tsui // Science. – 1989.
– Vol. 245, № 4922. – з P. 1073-1080.153. Imbalance between 95 kDa type IV collagenase and tissue inhibitor ofmetalloproteinases in sputum of patients with cystic fibrosis / C. Delacourt, M. LeBourgeois, M.P. D’Ortho, C. Doit, P. Scheinmann, J. Navarro, A. Harf, D.J. Hartmann,C. Lafuma // Am.
J. Respir. Crit. Care Med. – 1995. – Vol. 152, № 2. – P. 765-774.154. Individual matrix metalloproteinases control distinct transcriptionalresponses in airway epithelial cells infected with Pseudomonas aeruginosa / S.Y.Кassim, S.A. Gharib, B.H. Mecham, T.P. Birkland, W.C. Parks, J.K. McGuire //Infect. Immun. – 2007.
– Vol. 75, № 12. – P. 5640-5650.155. Inducible expression of tissue inhibitor of metalloproteinases-resistantmatrix metalloproteinase-9 on the cell surface of neutrophils / C.A. Owen, Z. Hu, B.Barrick, S.D. Shapiro // Am. J. Respir. Cell Mol. Biol. – 2003. – Vol. 29, № 3. – Pt. 1.– P. 283-294.156. Inflammatory response of coronary artery disease postmenopausal womenis associated with the IVS1-397T > C estrogen receptor alpha polymorphism / J.Mysliwska, A. Rutkowska, L.
Hak, J. Siebert, K. Szyndler, D. Rachon // Clin.Immunol. – 2009. – Vol. 130, № 3. – P. 355-364.204157. Inhibition of matrix metalloproteinase MMP-2 activates chloride currentin human airway epithelial cells / M. Duszyk, Y. Shu, G. Sawicki, A. Radomski, S.F.Man, M.W. Radomski // Can. J.
Physiol. Pharmacol. – 1999. – Vol. 77, № 7. – P. 529535.158. Interaction between a novel TGFB1 haplotype and CFTR genotype isassociated with improved lung function in cystic fibrosis / L.A. Bremer, S.M.Blackman, L.L. Vanscoy, K.E. McDougal, A. Bowers, K.M. Naughton, D.J. Cutler,C.R. Cutting // Hum. Mol. Genet. – 2008. – Vol.
17, № 14. – P. 2228-2237.159. International nosology of heritable disorders of connective tissue / P.Beighton, A. de Paepe, D. Danks, G. Finidori, T. Gedde-Dahl, R. Goodman, J.G. Hall,D.W. Hollister, W. Horton, V.A. McKusick // Am. J. Med.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
